Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
More info on cardiology's push for a new, independent medical board | PFA's potential | Empagliflozin & CKD
Monday, September 25, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Q&A: A closer look at the push in cardiology for a new, independent American Board of Cardiovascular Medicine

American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 

READ MORE >
Illustration of cardiologists going through the certification process. American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 
Share on Twitter Share on Facebook Share on Linkedin

Q&A: A closer look at the push in cardiology for a new, independent American Board of Cardiovascular Medicine

Share on Twitter Share on Facebook Share on Linkedin
Illustration of cardiologists going through the certification process. American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 
American College of Cardiology President B. Hadley Wilson, MD, discussed why the ACC and other leading cardiology groups are so eager to create a new, independent medical board. This has been a long-term goal for many years, he said, and now it may become a reality. 
READ MORE >

Pulsed field ablation shows potential to replace thermal ablation

Vivek Reddy, MD, explained that pulsed field ablation is associated with many benefits compared to the current standard of care in electrophysiology. 

READ MORE >
Vivek Reddy, MD, director of arrhythmia service and processor of medicine in cardiac electrophysiology, Mt. Sinai, New York, expolains the key takeaways from the ADVENT trial of pulsed field ablation at ESC 2023.
Share on Twitter Share on Facebook Share on Linkedin

Pulsed field ablation shows potential to replace thermal ablation

Share on Twitter Share on Facebook Share on Linkedin
Vivek Reddy, MD, director of arrhythmia service and processor of medicine in cardiac electrophysiology, Mt. Sinai, New York, expolains the key takeaways from the ADVENT trial of pulsed field ablation at ESC 2023.
Vivek Reddy, MD, explained that pulsed field ablation is associated with many benefits compared to the current standard of care in electrophysiology. 
READ MORE >

FDA approves empagliflozin for treating chronic kidney disease

The popular SGLT2 inhibitor, sold by Boehringer Ingelheim and Eli Lilly and Company under the name Jardiance, has already been approved by the FDA to treat type 2 diabetes and heart failure.

READ MORE >
Damaged Organ
Share on Twitter Share on Facebook Share on Linkedin

FDA approves empagliflozin for treating chronic kidney disease

Share on Twitter Share on Facebook Share on Linkedin
Damaged Organ
The popular SGLT2 inhibitor, sold by Boehringer Ingelheim and Eli Lilly and Company under the name Jardiance, has already been approved by the FDA to treat type 2 diabetes and heart failure.
READ MORE >

Featured Articles

The 50 best hospitals in the world for cardiac surgery

The new ranking, based on extensive survey data gathered by Newsweek, includes a total of 150 hospitals. Seven of the top 10 are located in the United States. 

READ MORE >
A study that analyzed patient outcomes in coronary artery bypass grafting (CABG) in veterans showed outcomes for on-pump and off-pump procedures over 10 years to be similar. Photo by Jim Lennon
Share on Twitter Share on Facebook Share on Linkedin

The 50 best hospitals in the world for cardiac surgery

Share on Twitter Share on Facebook Share on Linkedin
A study that analyzed patient outcomes in coronary artery bypass grafting (CABG) in veterans showed outcomes for on-pump and off-pump procedures over 10 years to be similar. Photo by Jim Lennon
The new ranking, based on extensive survey data gathered by Newsweek, includes a total of 150 hospitals. Seven of the top 10 are located in the United States. 
READ MORE >

Time for a change? Cardiology groups announce plan to develop a new medical board independent of the ABIM

"We know that the cardiovascular community is ready for an independent, self-governed entity, and we are proud to develop this new board with cardiologists and cardiology organizations at the helm," ACC President B. Hadley Wilson, MD, said in a statement.

READ MORE >
women doctors
Share on Twitter Share on Facebook Share on Linkedin

Time for a change? Cardiology groups announce plan to develop a new medical board independent of the ABIM

Share on Twitter Share on Facebook Share on Linkedin
women doctors
"We know that the cardiovascular community is ready for an independent, self-governed entity, and we are proud to develop this new board with cardiologists and cardiology organizations at the helm," ACC President B. Hadley Wilson, MD, said in a statement.
READ MORE >

In Case You Missed It

American College of Cardiology targets preventable heart disease with new screening campaign

The ACC has joined forces with Amgen and Esperion Therapeutics to increase LDL screening in patients with and without a history of cardiovascular issues.

READ MORE >
doctor with overweight patient who may be treated with TAVR or surgery
Share on Twitter Share on Facebook Share on Linkedin

American College of Cardiology targets preventable heart disease with new screening campaign

Share on Twitter Share on Facebook Share on Linkedin
doctor with overweight patient who may be treated with TAVR or surgery
The ACC has joined forces with Amgen and Esperion Therapeutics to increase LDL screening in patients with and without a history of cardiovascular issues.
READ MORE >

FDA approves new minimally invasive CLTI treatment for ‘no-option’ patients at risk of amputation

The new device, the first of its kind to gain FDA approval, was designed for patients who have no other endovascular or surgical options available to them.

READ MORE >
LimFlow, a medical device company with locations in California and Paris, has gained approval from the U.S. Food and Drug Administration (FDA) for its LimFlow System for Transcatheter Arterialization of Deep Veins. The LimFlow System was designed to help reestablish blood flow in chronic limb-threatening ischemia (CLTI) patients who face a high risk of amputation and have no other endovascular or surgical options available to them.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves new minimally invasive CLTI treatment for ‘no-option’ patients at risk of amputation

Share on Twitter Share on Facebook Share on Linkedin
LimFlow, a medical device company with locations in California and Paris, has gained approval from the U.S. Food and Drug Administration (FDA) for its LimFlow System for Transcatheter Arterialization of Deep Veins. The LimFlow System was designed to help reestablish blood flow in chronic limb-threatening ischemia (CLTI) patients who face a high risk of amputation and have no other endovascular or surgical options available to them.
The new device, the first of its kind to gain FDA approval, was designed for patients who have no other endovascular or surgical options available to them.
READ MORE >

In Other News

FTC sues private equity firm, claims it’s trying to build a monopoly in radiology

Welsh Carson created US Anesthesia Partners to consolidate the market in Texas and then attempted to do the same in imaging and EM, authorities allege. 

READ MORE >
court judge gavel business man bankruptcy lawsuit
Share on Twitter Share on Facebook Share on Linkedin

FTC sues private equity firm, claims it’s trying to build a monopoly in radiology

Share on Twitter Share on Facebook Share on Linkedin
court judge gavel business man bankruptcy lawsuit
Welsh Carson created US Anesthesia Partners to consolidate the market in Texas and then attempted to do the same in imaging and EM, authorities allege. 
READ MORE >

More and more hospitals are using the cloud for medical image storage

Cloud data storage is growing in medical imaging as a way of simplifying workflows and providing relief to health IT teams, Esteban Rubens explained in an interview. 

READ MORE >
Esteban Rubens, Oracle cloud field chief technology officer for healthcare, explains cloud’s role in enterprise imaging and healthcare IT and the movement away from on-premise data storage.
Share on Twitter Share on Facebook Share on Linkedin

More and more hospitals are using the cloud for medical image storage

Share on Twitter Share on Facebook Share on Linkedin
Esteban Rubens, Oracle cloud field chief technology officer for healthcare, explains cloud’s role in enterprise imaging and healthcare IT and the movement away from on-premise data storage.
Cloud data storage is growing in medical imaging as a way of simplifying workflows and providing relief to health IT teams, Esteban Rubens explained in an interview. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: Using hydroxychloroquine, azithromycin to treat COVID-19 | Are patients afraid to seek medical attention?
The many challenges hospitals face during COVID-19 pandemic | Are patients afraid to seek medical attention?
Providing emergency care for children with COVID-19 | AI assesses cardiac function faster than cardiologists
Pandemic watch: The biggest COVID-19 news in cardiology, all in one place
Week in Review: When the risk of death from COVID-19 skyrockets | Burnout in cardiology | Hypertension & COVID-19
Stroke surgeons share COVID-19 warning | Cardiologist-led COVID-19 research | E-cigarettes & smoking
Hypertension | April 2020

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …346
    • Page 347
    • Page 348
    • Page 349
    • Current page 350
    • Page 351
    • Page 352
    • Page 353
    • Page 354
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup